Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
J Autoimmun
    October 2025
  1. AN X, Huang X
    Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases.
    J Autoimmun. 2025;157:103495.
    >> Share

  2. WANG Y, Yang S, Yu Y, Xia P, et al
    Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study.
    J Autoimmun. 2025;157:103489.
    >> Share

    September 2025
  3. FUKUI S, Michitsuji T, Endo Y, Nishino A, et al
    Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis.
    J Autoimmun. 2025;157:103490.
    >> Share

  4. LIU X, Wang C, Guan X
    Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus.
    J Autoimmun. 2025;157:103488.
    >> Share

  5. STASCHEIT F, Schulze D, Lehnerer S, Gerischer L, et al
    Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy-A pilot study.
    J Autoimmun. 2025;157:103476.
    >> Share

  6. KELLY S, Singh M, Russell A, Jackson KJL, et al
    Lymphoma driver mutations at the root of somatic evolution of nerve-damaging autoantibodies in myelin associated glycoprotein neuropathy.
    J Autoimmun. 2025;157:103474.
    >> Share

  7. SONG Y, Zhou B, Long J, Peng Y, et al
    Targeted protein degradation in autoimmune diseases: from mechanisms to therapeutic breakthroughs.
    J Autoimmun. 2025;156:103475.
    >> Share

  8. MALHAM M, Sejling C, Davies M, Wewer V, et al
    How early-life adversity affects the risk of pediatric-onset immune-mediated inflammatory disease.
    J Autoimmun. 2025;156:103457.
    >> Share

    August 2025
  9. ZHU M, Li X, Zhao K, Huang Z, et al
    Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases.
    J Autoimmun. 2025;156:103472.
    >> Share

  10. YI X, Zimath PL, Martin-Vazquez E, Oliveira JG, et al
    Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic beta-cell protection.
    J Autoimmun. 2025;156:103469.
    >> Share

  11. HEBBANDI NANJUNDAPPA R, Kolla HB, Edgar A, Leung PS, et al
    Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis.
    J Autoimmun. 2025;156:103473.
    >> Share

  12. WANG Y, Wang S, Liu W, Gu H, et al
    Corrigendum to "Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice" [J. Autoimmun. 145 (2024) 103205].
    J Autoimmun. 2025 Aug 2:103470. doi: 10.1016/j.jaut.2025.103470.
    >> Share

    July 2025
  13. SENDO S, Vela AJ, Ro M, Thiruppathy D, et al
    Interaction between haploinsufficiency of PTPN2 and patient microbiome promotes autoimmune arthritis in mice.
    J Autoimmun. 2025;156:103452.
    >> Share

  14. OTT R, Singh T, Schutte-Borkovec K, Scholz M, et al
    Epigenetic differences at immune and type 1 diabetes susceptibility genes in blood from young children after COVID-19 infection.
    J Autoimmun. 2025;156:103468.
    >> Share

    June 2025
  15. PIREDDU MP, Rizzo G, Congiu F, Chessa E, et al
    Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus.
    J Autoimmun. 2025;155:103455.
    >> Share

  16. VAN DEN BEUKEL MD, Zhang L, van der Meulen S, Borggreven NV, et al
    Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.
    J Autoimmun. 2025;155:103444.
    >> Share

  17. LEE YJ, Fang YW, Chen MT, Liou HH, et al
    Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study.
    J Autoimmun. 2025;155:103453.
    >> Share

  18. RENAUDINEAU Y, Sposito F, Natoli V, Charras A, et al
    Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus.
    J Autoimmun. 2025;155:103451.
    >> Share

  19. SAKSAGER AB, Hede FD, Barra C
    Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases.
    J Autoimmun. 2025;155:103443.
    >> Share

    May 2025
  20. HOCAOGLU M, Sawalha AH
    Integrated analysis of polygenic and environmental risk scores for late-onset systemic lupus erythematosus.
    J Autoimmun. 2025;154:103441.
    >> Share

  21. VAN DOOREN HJ, Atisha-Fregoso Y, Dorjee AL, Huizinga TWJ, et al
    Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus.
    J Autoimmun. 2025;154:103438.
    >> Share

  22. LEE S, Jo AR, Kim Y, Lee W, et al
    Association between occupational and environmental dust exposure and autoimmune diseases: A systematic review and meta-analysis.
    J Autoimmun. 2025;154:103440.
    >> Share

  23. MAZZUCATO-PUCHNER A, Ramspeck H, Ritschl V, Stamm T, et al
    Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study.
    J Autoimmun. 2025;154:103439.
    >> Share

  24. WANG P, Yuksel M, Gabeta S, Graham J, et al
    HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.
    J Autoimmun. 2025;154:103436.
    >> Share

  25. SU QY, Zheng XX, Han XT, Li Q, et al
    The role of age-associated B cells in systemic lupus erythematosus.
    J Autoimmun. 2025;154:103433.
    >> Share

  26. HU H, Peng Y, Wang CC, Chen J, et al
    Neutrophil extracellular traps induce trophoblasts pyroptosis via enhancing NLRP3 lactylation in SLE pregnancies.
    J Autoimmun. 2025;153:103411.
    >> Share

  27. KNOX JJ, Scholz JL, Futeran H, Cataliotti S, et al
    T-bet(+)CD11c(+) age-associated B cells resist BLyS- and CD20-targeted ablation in murine lupus models.
    J Autoimmun. 2025;153:103410.
    >> Share

  28. MATTIOLI I, Urban ML, Padoan R, Mohammad AJ, et al
    Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.
    J Autoimmun. 2025;153:103398.
    >> Share

    April 2025
  29. WANG L, Christodoulou MI, Jin Z, Ma Y, et al
    Human regulatory B cells suppress autoimmune disease primarily via interleukin-37.
    J Autoimmun. 2025;153:103415.
    >> Share

  30. CHEVALIER K, Thoreau B, Michel M, Godeau B, et al
    Treatment of mixed connective tissue disease: A multicenter retrospective study.
    J Autoimmun. 2025;153:103420.
    >> Share

  31. SHIRAHAMA S, Okunuki Y, Lee MY, Karg MM, et al
    Preventing the antigen-presenting function of retinal microglia blocks autoimmune neuroinflammation by dendritic cell-primed CD4(+) T cells.
    J Autoimmun. 2025;153:103417.
    >> Share

  32. YANG Y, Liu W, Zhang Z, Zhang Y, et al
    Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in autoimmune diseases.
    J Autoimmun. 2025;153:103414.
    >> Share

    March 2025
  33. HE J, Guo Y, Chen J, Xu J, et al
    Exploring the correlation between UVB sensitivity and SLE activity: Insights into UVB-driven pathogenesis in lupus erythematosus.
    J Autoimmun. 2025;153:103393.
    >> Share

  34. XU H, Zhan M, Wu Z, Chen J, et al
    Aberrant expansion of CD177(+) neutrophils promotes endothelial dysfunction in systemic lupus erythematosus via neutrophil extracellular traps.
    J Autoimmun. 2025;152:103399.
    >> Share

  35. ZHANG S, Wen Q, Su S, Wang Y, et al
    Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis.
    J Autoimmun. 2025;152:103395.
    >> Share

  36. RAUBER S, Schulte-Mecklenbeck A, Sarink K, Golombeck KS, et al
    Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis.
    J Autoimmun. 2025;152:103396.
    >> Share

  37. NOELKER C, Seitz F, Sturn A, Neff F, et al
    Autoantibodies against alpha-synuclein inhibit its aggregation and cytotoxicity.
    J Autoimmun. 2025;152:103390.
    >> Share

  38. SU C, Cong A, Wu H, Zhou Z, et al
    Glomerular CD68(+) macrophages infiltration at initial biopsy predicts response to standard immunosuppression in proliferative lupus nephritis: CD68(+) Mo predicts LN treatment response.
    J Autoimmun. 2025;152:103392.
    >> Share

  39. ATTRILL MH, Shinko D, Viveiros TM, Milighetti M, et al
    Treg fitness signatures as a biomarker for disease activity in Juvenile Idiopathic Arthritis.
    J Autoimmun. 2025;152:103379.
    >> Share

    February 2025
  40. WANG R, Lin Q, Sheng L, Zhang Y, et al
    Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitis.
    J Autoimmun. 2025;152:103387.
    >> Share

  41. WEBER A, Zulcinski M, Haroon-Rashid L, Kuszlewicz B, et al
    Identification of clonally expanded T-cell receptor sequences in giant cell arteritis.
    J Autoimmun. 2025;151:103372.
    >> Share

  42. SCIME NV, Grandi SM, De Vera MA, Dennis CL, et al
    Primary Cesarean delivery and future risk of maternal autoimmune disease: A population-based cohort study.
    J Autoimmun. 2025;151:103370.
    >> Share

  43. HUANG Y, Jee E, Kim M, Liu X, et al
    Familial patterns of alopecia areata: A systematic review and meta-analysis.
    J Autoimmun. 2025;151:103378.
    >> Share

    January 2025
  44. LI J, Xie Z, Yang L, Guo K, et al
    The impact of gut microbiome on immune and metabolic homeostasis in type 1 diabetes: Clinical insights for prevention and treatment strategies.
    J Autoimmun. 2025;151:103371.
    >> Share

  45. UPPIN V, Gibbons H, Troje M, Feinberg D, et al
    CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy.
    J Autoimmun. 2025;151:103369.
    >> Share

  46. AROWOSEGBE A, Guo Z, Vanderleeden E, Derr AG, et al
    Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats.
    J Autoimmun. 2025;151:103358.
    >> Share

  47. LU Y, Man XY
    Diversity and function of regulatory T cells in health and autoimmune diseases.
    J Autoimmun. 2025;151:103357.
    >> Share

  48. ANDERSEN SS, Neumann TF, Dannesbo S, Raja AA, et al
    Maternal autoimmune systemic connective tissue disease and vasculitis and electrocardiographic findings in the offspring.
    J Autoimmun. 2025;150:103356.
    >> Share

  49. AKUTSU Y, Ota M, Itamiya T, Mori M, et al
    Effect of Epstein-Barr Virus infection on gene regulation in immune cells of patients with Immune-Mediated Diseases.
    J Autoimmun. 2025;150:103355.
    >> Share

    December 2024
  50. ZENG L, Li Y, Xiang W, Xiao W, et al
    Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications.
    J Autoimmun. 2024;150:103350.
    >> Share

  51. MAHDY AKH, Lokes E, Schopfel V, Kriukova V, et al
    Bulk T cell repertoire sequencing (TCR-Seq) is a powerful technology for understanding inflammation-mediated diseases.
    J Autoimmun. 2024;149:103337.
    >> Share

  52. SORIN B, Papo M, Sinico RA, Teixeira VS, et al
    Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
    J Autoimmun. 2024;149:103338.
    >> Share

  53. BERTI A, Tomasi M, Pesce I, Lista E, et al
    Identification of the central tolerance checkpoint for autoreactive proteinase 3(+) B cells in human bone marrow.
    J Autoimmun. 2024;149:103330.
    >> Share

  54. LONG H, Espinosa L, Sawalha AH
    Unraveling the immunomodulatory impact of hydroxychloroquine on peripheral T cells using single-cell RNA sequencing.
    J Autoimmun. 2024;149:103324.
    >> Share

  55. EHRSTROM A, Jansson S, Jorgensen MH, Wewer V, et al
    The risk of cancer in pediatric-onset immune-mediated inflammatory diseases - A nationwide study.
    J Autoimmun. 2024;149:103321.
    >> Share

  56. PENG X, Wang S, Wu K, Cook C, et al
    Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis.
    J Autoimmun. 2024;149:103307.
    >> Share

  57. MAZ MP, Reddy AL, Berthier CC, Tsoi LC, et al
    Lupus-prone NZM2328 mice exhibit enhanced UV-induced myeloid cell recruitment and activation in a type I interferon dependent manner.
    J Autoimmun. 2024;149:103296.
    >> Share

    November 2024
  58. FENG Y, Deyanat-Yazdi G, Newburn K, Potter S, et al
    PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation - therapeutic implications for autoimmunity.
    J Autoimmun. 2024;149:103339.
    >> Share

  59. YANG Y, Li M, Ding L, Zhang Y, et al
    EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification.
    J Autoimmun. 2024;149:103341.
    >> Share

  60. NOTARNICOLA A, Hellstrom C, Horuluoglu B, Pin E, et al
    Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.
    J Autoimmun. 2024;149:103332.
    >> Share

  61. YANGINLAR C, Rother N, Post TGJM, Jacobs M, et al
    Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus.
    J Autoimmun. 2024;149:103335.
    >> Share

  62. SU QY, Jiang ZQ, Song XY, Zhang SX, et al
    Regulatory B cells in autoimmune diseases: Insights and therapeutic potential.
    J Autoimmun. 2024;149:103326.
    >> Share

  63. HU SZ, Yuan ZY, Zhang XX, Yu XJ, et al
    The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential.
    J Autoimmun. 2024;149:103329.
    >> Share

  64. PERURENA-PRIETO J, Sanz-Martinez MT, Vinas-Gimenez L, Codina-Clavaguera C, et al
    Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing.
    J Autoimmun. 2024;149:103328.
    >> Share

    October 2024
  65. KALIN T, Passarin K, Filipowic-Sinnreich M, Semela D, et al
    SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases.
    J Autoimmun. 2024;149:103325.
    >> Share

  66. IIJIMA N, Yamaguchi M, Hayashi T, Rui Y, et al
    miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases.
    J Autoimmun. 2024;149:103319.
    >> Share

  67. HASSLER S, Lorenzon R, Binvignat M, Ribet C, et al
    Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases.
    J Autoimmun. 2024;149:103318.
    >> Share

    September 2024
  68. HUA Y, Jiang P, Dai C, Li M, et al
    Extracellular vesicle autoantibodies.
    J Autoimmun. 2024;149:103322.
    >> Share

  69. BLANK M, Israeli D, Shoenfeld Y
    Exercise, autoimmune diseases and T-regulatory cells.
    J Autoimmun. 2024;149:103317.
    >> Share

  70. PETER B, Rebeaud J, Vigne S, Bressoud V, et al
    Perivascular B cells link intestinal angiogenesis to immunity and to the gut-brain axis during neuroinflammation.
    J Autoimmun. 2024;148:103292.
    >> Share

  71. LI C, Liu H, Yang L, Liu R, et al
    Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments.
    J Autoimmun. 2024;148:103286.
    >> Share

    August 2024
  72. ZENG L, Yang K, Wu Y, Yu G, et al
    Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases.
    J Autoimmun. 2024;148:103291.
    >> Share

  73. ROJAS M, Acosta-Ampudia Y, Heuer LS, Zang W, et al
    Antigen-specific T cells and autoimmunity.
    J Autoimmun. 2024;148:103303.
    >> Share

  74. OAKES EG, Dillon E, Buhler KA, Guan H, et al
    Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.
    J Autoimmun. 2024;148:103299.
    >> Share

    July 2024
  75. LIU Q, Jiang Y, Frisell T, Stridh P, et al
    Shared aetiology underlying multiple sclerosis and other immune mediated inflammatory diseases: Swedish familial co-aggregation and large-scale genetic correlation analyses.
    J Autoimmun. 2024;148:103294.
    >> Share

  76. ALVAREZ-LOPEZ AI, Alvarez-Sanchez N, Cruz-Chamorro I, Santos-Sanchez G, et al
    Melatonin synergistically potentiates the effect of methylprednisolone on reducing neuroinflammation in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    J Autoimmun. 2024;148:103298.
    >> Share

  77. BERRYMAN MA, Ilonen J, Triplett EW, Ludvigsson J, et al
    Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease.
    J Autoimmun. 2024;148:103290.
    >> Share

  78. BOGERS L, Rip J, Rijvers L, van Langelaar J, et al
    Impact of coding risk variant IFNGR2 on the B cell-intrinsic IFN-gamma signaling pathway in multiple sclerosis.
    J Autoimmun. 2024;148:103279.
    >> Share

  79. SOLIGNAC M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, et al
    JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study.
    J Autoimmun. 2024;147:103248.
    >> Share

  80. LEI L, Feng S
    Immune interplay from circulation to local lesion in pemphigus pathogenesis.
    J Autoimmun. 2024;147:103261.
    >> Share

  81. MANNING JE, Harris E, Mathieson H, Sorensen L, et al
    Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    J Autoimmun. 2024;147:103260.
    >> Share

    June 2024
  82. YUAN L, Wang Y, Shen X, Ma F, et al
    Soluble form of immune checkpoints in autoimmune diseases.
    J Autoimmun. 2024;147:103278.
    >> Share

  83. TSAY GJ, Zouali M
    Cellular pathways and molecular events that shape autoantibody production in COVID-19.
    J Autoimmun. 2024;147:103276.
    >> Share

  84. HU P, Xiao H, Elmore S, Agosto-Burgos C, et al
    Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice.
    J Autoimmun. 2024;147:103266.
    >> Share

  85. FAN G, Li G, Li L, Da Y, et al
    Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation.
    J Autoimmun. 2024;147:103262.
    >> Share

  86. HANKARD A, Maalouf G, Laouni J, Espitia O, et al
    Outcome and prognosis of isolated carotid vasculitis.
    J Autoimmun. 2024;146:103242.
    >> Share

  87. BONASIA CG, Inrueangsri N, Bijma T, Mennega KP, et al
    Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity.
    J Autoimmun. 2024;146:103236.
    >> Share

  88. LI Q, Jia C, Pan W, Liu H, et al
    Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients.
    J Autoimmun. 2024;146:103203.
    >> Share

    May 2024
  89. CHOE YH, Jo MG, Kim BG, Lee S, et al
    The autoimmune response induced by alpha-synuclein peptides drives neuronal cell death and glial cell activation.
    J Autoimmun. 2024;147:103256.
    >> Share

  90. HEMON M, Giassi M, Ghaffar Y, Martin M, et al
    Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies.
    J Autoimmun. 2024;146:103238.
    >> Share

  91. ESTUPINAN-MORENO E, Hernandez-Rodriguez J, Li T, Ciudad L, et al
    Decoding CD4(+) T cell transcriptome in giant cell arteritis: Novel pathways and altered cross-talk with monocytes.
    J Autoimmun. 2024;146:103240.
    >> Share

  92. AKATSU C, Tsuneshige T, Numoto N, Long W, et al
    CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
    J Autoimmun. 2024;146:103245.
    >> Share

  93. DAS S, Stamnaes J, Hoydahl LS, Skagen C, et al
    Selective activation of naive B cells with unique epitope specificity shapes autoantibody formation in celiac disease.
    J Autoimmun. 2024;146:103241.
    >> Share

  94. YANG Y, Jiang H, Tang Z, Pan H, et al
    Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice.
    J Autoimmun. 2024;146:103237.
    >> Share

  95. ZOU X, Huo F, Sun L, Huang J, et al
    Peripheral helper T cells in human diseases.
    J Autoimmun. 2024;145:103218.
    >> Share

  96. WANG K, Hou X, Lu H, Han N, et al
    Ectopic CD4(+) T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-gamma induced microglia activation.
    J Autoimmun. 2024;145:103199.
    >> Share

  97. LIN M, Huang L, Huang J, Yu J, et al
    Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
    J Autoimmun. 2024;145:103198.
    >> Share

    April 2024
  98. HUANG B, Li H, Jiang Q, Li Y, et al
    Elevated type I IFN signalling directly affects CD8(+) T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients.
    J Autoimmun. 2024;146:103232.
    >> Share

  99. LI J, Cheng C, Zhang J
    Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis.
    J Autoimmun. 2024;146:103231.
    >> Share

  100. ESEN I, Sandovici M, Heeringa P, Boots AMH, et al
    Impaired IL-6-induced JAK-STAT signaling in CD4(+) T cells associates with longer treatment duration in giant cell arteritis.
    J Autoimmun. 2024;146:103215.
    >> Share

  101. CHUANG HC, Lan KY, Hsu PM, Chen MH, et al
    UHRF1P contributes to IL-17A-mediated systemic lupus erythematosus via UHRF1-MAP4K3 axis.
    J Autoimmun. 2024;146:103221.
    >> Share

  102. DO JS, Arribas-Layton D, Juan J, Garcia I, et al
    The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation.
    J Autoimmun. 2024;146:103228.
    >> Share

  103. WORZNER K, Zimmermann J, Buhl R, Desoi A, et al
    Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype.
    J Autoimmun. 2024;144:103174.
    >> Share

  104. STUCCHI A, Maspes F, Montee-Rodrigues E, Fousteri G, et al
    Engineered Treg cells: The heir to the throne of immunotherapy.
    J Autoimmun. 2024;144:102986.
    >> Share

    March 2024
  105. DZIEDZIC A, Michlewska S, Jozwiak P, Debski J, et al
    Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS).
    J Autoimmun. 2024;145:103204.
    >> Share

  106. WANG Y, Wang S, Liu W, Gu H, et al
    Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice.
    J Autoimmun. 2024;145:103205.
    >> Share

  107. HUANG W, Jin T, Zheng W, Yin Q, et al
    Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases.
    J Autoimmun. 2024;145:103188.
    >> Share

  108. GARCIA-LOZA I, Perna-Barrull D, Aguilera E, Almenara-Fuentes L, et al
    Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
    J Autoimmun. 2024;145:103196.
    >> Share

  109. CHAVULA T, To S, Smith J, Pedroza M, et al
    CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.
    J Autoimmun. 2024;145:103197.
    >> Share

    February 2024
  110. BONACINI M, Rossi A, Ferrigno I, Muratore F, et al
    miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.
    J Autoimmun. 2024;144:103186.
    >> Share

  111. FISCHER S, Meisinger C, Freuer D
    Autoimmune diseases and female-specific cancer risk: A systematic review and meta-analysis.
    J Autoimmun. 2024;144:103187.
    >> Share

  112. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
    The enigma of sclera-specific autoimmunity in scleritis.
    J Autoimmun. 2024;144:103178.
    >> Share

  113. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
    Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
    J Autoimmun. 2024;144:103180.
    >> Share

  114. NEYS SFH, Heutz JW, van Hulst JAC, Vink M, et al
    Aberrant B cell receptor signaling in circulating naive and IgA(+) memory B cells from newly-diagnosed autoantibody-positive rheumatoid arthritis patients.
    J Autoimmun. 2024;143:103168.
    >> Share

  115. LORENZON R, Ribet C, Pitoiset F, Aractingi S, et al
    The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
    J Autoimmun. 2024;144:103172.
    >> Share

  116. TAIEB D, Moyon Q, Lhote R, Annesi-Maesano I, et al
    Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
    J Autoimmun. 2024;144:103173.
    >> Share

    January 2024
  117. ZHONG T, Li X, Lei K, Tang R, et al
    CXCL12-CXCR4 mediates CD57(+) CD8(+) T cell responses in the progression of type 1 diabetes.
    J Autoimmun. 2024;143:103171.
    >> Share

  118. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Older age of celiac disease diagnosis and risk of autoimmune disease: A nationwide matched case-control study.
    J Autoimmun. 2024;143:103170.
    >> Share

  119. LINDELOF L, Rantapaa-Dahlqvist S, Lundtoft C, Sandling JK, et al
    A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile.
    J Autoimmun. 2024;143:103166.
    >> Share

  120. LI Y, Tang C, Vanarsa K, Thai N, et al
    Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    J Autoimmun. 2024;143:103165.
    >> Share

  121. REUSCHLE Q, Van Heddegem L, Bosteels V, Moncan M, et al
    Loss of function of XBP1 splicing activity of IRE1alpha favors B cell tolerance breakdown.
    J Autoimmun. 2024;142:103152.
    >> Share

  122. LIBERATORE J, Nguyen Y, Hadjadj J, Cohen P, et al
    Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study.
    J Autoimmun. 2024;142:103130.
    >> Share

  123. KELLY S, Jackson KJ, Peters TJ, Suan D, et al
    Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences.
    J Autoimmun. 2024;142:103129.
    >> Share

  124. REYNOLDS JA, Li Y, Herlitz L, Mohan C, et al
    Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum.
    J Autoimmun. 2024;142:103134.
    >> Share

  125. XU C, Zhang T, Wang H, Zhu L, et al
    Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus.
    J Autoimmun. 2024;142:103128.
    >> Share

  126. MERINO-VICO A, van Hamburg JP, Tuijnenburg P, Frazzei G, et al
    Targeting NF-kappaB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.
    J Autoimmun. 2024;142:103133.
    >> Share

    December 2023
  127. PENG X, Li H, Zhu L, Zhao S, et al
    Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis.
    J Autoimmun. 2023;143:103160.
    >> Share

  128. GAO L, Zhang W, Zhang L, Gromova B, et al
    Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis.
    J Autoimmun. 2023;143:103162.
    >> Share

  129. BENDER C, Muller P, Tondello C, Horn J, et al
    Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
    J Autoimmun. 2023;143:103161.
    >> Share

  130. SOMERS EC, Goodrich JM, Wang L, Harlow SD, et al
    Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program.
    J Autoimmun. 2023;142:103137.
    >> Share

  131. SHAO T, Hsu R, Rafizadeh DL, Wang L, et al
    The gut ecosystem and immune tolerance.
    J Autoimmun. 2023;141:103114.
    >> Share

  132. GUO Z, Yiu N, Hu Z, Zhou W, et al
    Alterations of fecal microbiome and metabolome in pemphigus patients.
    J Autoimmun. 2023;141:103108.
    >> Share

    November 2023
  133. GREIGERT H, Ramon A, Genet C, Cladiere C, et al
    Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
    J Autoimmun. 2023;142:103151.
    >> Share

  134. YASUDA K, Shimodan S, Maehara N, Hirota A, et al
    AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions.
    J Autoimmun. 2023;142:103149.
    >> Share

  135. CARMONA EG, Callejas-Rubio JL, Raya E, Rios-Fernandez R, et al
    Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4(+) T cells in giant cell arteritis.
    J Autoimmun. 2023;142:103124.
    >> Share

  136. LABERE B, Nguyen AA, Habiballah SB, Elkins M, et al
    Clinical utility of measuring CD4(+) T follicular cells in patients with immune dysregulation.
    J Autoimmun. 2023;140:103088.
    >> Share

    October 2023
  137. KISHIMOTO TK, Fournier M, Michaud A, Rizzo G, et al
    Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
    J Autoimmun. 2023;140:103125.
    >> Share

  138. LI Y, Song H, Meng X, Li R, et al
    Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review.
    J Autoimmun. 2023;140:103121.
    >> Share

  139. ERDEI E, O'Donald ER, Luo L, Enright K, et al
    Comparison of circulating and excreted metals and of autoimmunity between two Great Plains Tribal communities.
    J Autoimmun. 2023 Oct 7:103117. doi: 10.1016/j.jaut.2023.103117.
    >> Share

  140. DU Y, Brodeur KE, Hsu E, Chen L, et al
    In cis "benign" SOCS1 variants linked to enhanced interferon signaling and autoimmunity.
    J Autoimmun. 2023;140:103119.
    >> Share

    September 2023
  141. MISTRY S, Gouripeddi R, Facelli JC
    Prioritization of infectious epitopes for translational investigation in type 1 diabetes etiology.
    J Autoimmun. 2023;140:103115.
    >> Share

  142. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469].
    J Autoimmun. 2023 Sep 23:103116. doi: 10.1016/j.jaut.2023.103116.
    >> Share

  143. WINANS T, Oaks Z, Choudhary G, Patel A, et al
    mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
    J Autoimmun. 2023;140:103112.
    >> Share

  144. TERZIROLI BERETTA-PICCOLI B, Buescher G, Dalekos G, Zachou K, et al
    Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.
    J Autoimmun. 2023;140:103113.
    >> Share

  145. LIN Y, Sakuraba S, Massilamany C, Reddy J, et al
    Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.
    J Autoimmun. 2023;140:103094.
    >> Share

  146. GRAVER JC, Jiemy WF, Altulea DHA, van Sleen Y, et al
    Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
    J Autoimmun. 2023;140:103111.
    >> Share

  147. LIU X, Liu M, Zhao M, Li P, et al
    Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges.
    J Autoimmun. 2023 Sep 8:103109. doi: 10.1016/j.jaut.2023.103109.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016